Study of physician and patient communication identifies missed opportunities to help reduce patients' out-of-pocket spending

Health Affairs

Volumn 35, Issue 4, 2016, Pages 654-661

  Ubel, Peter A ^a,b   Zhang, Cecilia J ^c   Hesson, Ashley ^d   Kelly Davis, J ^a   Kirby, Christine ^a   Barnett, Jamison ^e   Hunter, Wynn G ^c  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL STUDY; CONSUMER; CONVERSATION; DOCTOR PATIENT RELATION; HUMAN; MARKET; QUALITATIVE RESEARCH; TREATMENT FAILURE; UNCERTAINTY; ADULT; CLINICAL PRACTICE; COST OF ILLNESS; ECONOMICS; ETHICS; FEMALE; FINANCIAL MANAGEMENT; HEALTH CARE COST; INTERPERSONAL COMMUNICATION; MALE; MIDDLE AGED; UNITED STATES;

ADULT; COMMUNICATION; COST OF ILLNESS; FEMALE; FINANCING, PERSONAL; HEALTH EXPENDITURES; HUMANS; MALE; MIDDLE AGED; PHYSICIAN-PATIENT RELATIONS; PRACTICE PATTERNS, PHYSICIANS'; QUALITATIVE RESEARCH; UNITED STATES;

EID: 84964997220     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.2015.1280     Document Type: Article

References (27)

1. Henry J. Kaiser Family Foundation. 2015 Employer Health Benefits Survey [Internet]. Menlo Park (CA): KFF;2015 Sep 22 [cited 2016 Feb 18]. Available from: http://kff.org/health-costs/report/2015-employer-health-benefits-survey/.
2. Zweifel P, Manning WG. Moral hazard and consumer incentives in health care. In: Culyer AJ, Newhouse JP, editors. Handbook of health economics, volume 1A. Philadelphia (PA): Elsevier B.V.;2000 Jul. p. 409-59.
3. Motheral B, Fairman KA. Effect of a three-tier prescription copay on pharmaceutical and other medical utilization. Med Care. 2001;39(12): 1293-304.
4. Collins SR, Rasmussen PW, Doty MM, Beutel S. The rise in health care coverage and affordability since health reform took effect: findings from the Commonwealth Fund Biennial Health Insurance Survey, 2014. Issue Brief (Commonw Fund). 2005;2: 1-16.
5. Dusetzina SB, Winn AN, Abel GA, Huskamp HA, Keating NL. Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. J Clin Oncol. 2014;32(4): 306-11.
6. Neugut AI, Subar M, Wilde ET, Stratton S, Brouse CH, Hillyer GC, et al. Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer. J Clin Oncol. 2011;29(18): 2534-42.
7. Piette JD, Heisler M, Wagner TH. Cost-related medication underuse: do patients with chronic illnesses tell their doctors? Arch Intern Med. 2004;164(16):1749-55.
8. de Souza JA, Yap BJ, Hlubocky FJ, Wroblewski K, Ratain MJ, Cella D, et al. The development of a financial toxicity patient-reported outcome in cancer: the COST measure. Cancer. 2014;120(20): 3245-53.
9. Cook K, Dranove D, Sfekas A. Does major illness cause financial catastrophe? Health Serv Res. 2010;45(2):418-36.
10. Himmelstein DU, Thorne D, Warren E, Woolhandler S. Medical bankruptcy in the United States, 2007: results of a national study. Am J Med. 2009;122(8): 741-6.
11. Newhouse JP. Free for all? Lessons from the RAND Health Insurance Experiment. Cambridge (MA): Harvard University Press;1993.
12. Lohr KN, Brook RH, Kamberg C, Goldberg GA, Leibowitz A, Keesey J, et al. Use of medical care in the RAND Health Insurance Experiment: diagnosis- and service-specific analyses in a randomized controlled trial. Med Care. 1986;24(9 Suppl): S1-87.
13. Ubel PA, Abernethy AP, Zafar SY. Full disclosure-out-of-pocket costs as side effects. N Engl J Med. 2013;369(16): 1484-6.
14. Moriates C, Shah NT, Arora VM. First, do no (financial) harm. JAMA. 2013;310(6): 577-8.
15. Ubel PA. Can patients in the United States become savvy health care consumers? N.C.L. Rev. 2014;92: 1749-88.
16. Alexander GC, Casalino LP, Meltzer DO. Patient-physician communication about out-of-pocket costs. JAMA. 2003;290(7): 953-8.
17. Irwin B, Kimmick G, Altomare I, Marcom PK, Houck K, Zafar SY, et al. Patient experience and attitudes toward addressing the cost of breast cancer care. Oncologist. 2014;19(11): 1135-40.
18. Schmittdiel JA, Steers N, Duru OK, Ettner SL, Brown AF, Fung V, et al. Patient-provider communication regarding drug costs in Medicare Part D beneficiaries with diabetes: a TRIAD Study. BCM Health Serv Res. 2010;10: 164.
19. Beard AJ, Sleath B, Blalock SJ, Roth M, Weinberger M, Tudor G, et al. Predictors of rheumatoid arthritis patient-physician communication about medication costs during visits to rheumatologists. Arthritis Care Res (Hoboken). 2010;62(5): 632-9.
20. Hunter WG, Zhang CZ, Hesson A, Davis JK, Kirby C, Williamson LD, et al. What strategies do physicians and patients discuss to reduce outof-pocket costs? Analysis of cost-saving strategies in 1,755 outpatient clinic visits. Med Decis Making. 2016 Jan 19. [Epub ahead of print].
21. Bowen GA. Naturalistic inquiry and the saturation concept: a research note. Qual Res. 2008;8(1): 137-52.
22. Chabris C, Simons D. The invisible gorilla: how our intuitions deceive us. New York (NY): Crown;2010.
23. Catlin MK, Poisal JA, Cowan CA. Out-of-pocket health care expenditures, by insurance status, 2007-10. Health Aff (Millwood). 2015;34(1): 111-6.
24. Rosenthal E. Rapid price increases for some generic drugs catch users by surprise. New York Times [serial on the Internet]. 2014 Jul 8 [cited 2016 Feb 18]. Available from: http://www.nytimes.com/2014/07/09/health/some-generic-drug-prices-are-soaring.html.
25. Paez KA, Zhao L, Hwang W. Rising out-of-pocket spending for chronic conditions: a ten-year trend. Health Aff (Millwood). 2009;28(1): 15-25.
26. Riggs KR, Ubel PA. Overcoming barriers to discussing out-of-pocket costs with patients. JAMA Intern Med. 2014;174(6): 849-50.
27. Rosenthal JA, Lu X, Cram P. Availability of consumer prices from US hospitals for a common surgical procedure. JAMA Intern Med. 2013;173(6): 427-32.